Lexeo Therapeutics (LXEO) Equity Ratio: 2022-2023
- Lexeo Therapeutics' Equity Ratio was N/A to -2.98 in Q3 2023 from the same period last year, while for Sep 2023 it was -2.98, marking a year-over-year change of. This contributed to the annual value of -1.16 for FY2022, which is N/A change from last year.
- As of Q3 2023, Lexeo Therapeutics' Equity Ratio stood at -2.98, which was down 155.69% from -1.16 recorded in Q4 2022.
- In the past 5 years, Lexeo Therapeutics' Equity Ratio ranged from a high of -1.16 in Q4 2022 and a low of -2.98 during Q3 2023.
- Moreover, its 2-year median value for Equity Ratio was -2.07 (2022), whereas its average is -2.07.
